Tomas Kiselak's most recent trade in Viridian Therapeutics Inc was a trade of 21,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viridian Therapeutics Inc | Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) |